No abstract available
MeSH terms
-
Angiogenesis Inhibitors / pharmacology
-
Angiogenesis Inhibitors / therapeutic use
-
Animals
-
Antibodies, Monoclonal, Humanized / pharmacology
-
Antibodies, Monoclonal, Humanized / therapeutic use
-
BRCA1 Protein / metabolism
-
BRCA2 Protein / metabolism
-
Bevacizumab
-
Disease Models, Animal
-
Drug Evaluation, Preclinical*
-
Female
-
Humans
-
Mice
-
Mutation
-
Neoplasm Staging
-
Ovarian Neoplasms / drug therapy*
-
Ovarian Neoplasms / metabolism
-
Tumor Microenvironment / drug effects
-
Tumor Suppressor Protein p53 / genetics
-
Tumor Suppressor Protein p53 / metabolism
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal, Humanized
-
BRCA1 Protein
-
BRCA2 Protein
-
Tumor Suppressor Protein p53
-
Bevacizumab